Marrone Bio Innovations (NASDAQ: MBII)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-15 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.020 | -0.040 | -0.0200 | ||||
REV | 12.600M | 11.097M | -1.503M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Marrone Bio Innovations (NASDAQ: MBII) through any online brokerage.
Other companies in Marrone Bio Innovations’s space includes: Mosaic (NYSE:MOS), Intrepid Potash (NYSE:IPI), Corteva (NYSE:CTVA), CF Industries Holdings (NYSE:CF) and Scotts Miracle Gro (NYSE:SMG).
The latest price target for Marrone Bio Innovations (NASDAQ: MBII) was reported by Roth Capital on Wednesday, September 22, 2021. The analyst firm set a price target for 2.00 expecting MBII to rise to within 12 months (a possible 72.41% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Marrone Bio Innovations (NASDAQ: MBII) is $1.16 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Marrone Bio Innovations.
Marrone Bio Innovations’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Marrone Bio Innovations.
Marrone Bio Innovations is in the Materials sector and Chemicals industry. They are listed on the NASDAQ.